Article
Author(s):
DeepIntent, healthcare advertising technology company built to improve patient health and business outcomes, now offers pharmaceutical advertisers the ability to measure the real-world effectiveness of their entire media plan with the industry's fastest omnichannel measurement solution based on clinical data.
As part of the evolution of DeepIntent Outcomes™, the platform now features new measurement capabilities that surpass those of existing third-party measurement solutions, making it a one-stop shop for healthcare marketers. These features include:
These features are now available to all pharma marketers and across all platforms and publishers, irrespective of whether they run campaigns on DeepIntent's healthcare demand side platform (DSP).
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.